Institute of Organic Chemistry and Biochemistry, VVI, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
J Med Chem. 2010 May 27;53(10):4050-65. doi: 10.1021/jm100055b.
On the basis of the highly branched ovomucoid-type undecasaccharide that had been shown previously to be an endogenous ligand for CD69 leukocyte receptor, a systematic investigation of smaller oligosaccharide mimetics was performed based on linear and branched N-acetyl-d-hexosamine homooligomers prepared synthetically using hitherto unexplored reaction schemes. The systematic structure-activity studies revealed the tetrasaccharide GlcNAcbeta1-3(GlcNAcbeta1-4)(GlcNAcbeta1-6)GlcNAc (compound 52) and its alpha-benzyl derivative 49 as the best ligand for CD69 with IC(50) as high as 10(-9) M. This compound thus approaches the affinity of the classical high-affinity neoglycoprotein ligand GlcNAc(23)BSA. Compound 68, GlcNAc tetrasaccharide 52 dimerized through a hydrophilic flexible linker, turned out to be effective in activating CD69(+) lymphocytes. It also proved efficient in enhancing natural killing in vitro, decreasing the growth of tumors in vivo, and activating the CD69(+) tumor infiltrating lymphocytes examined ex vivo. This compound is thus a candidate for carbohydrate-based immunomodulators with promising antitumor potential.
在先前已经证明的高支化卵类黏蛋白型十一聚糖是 CD69 白细胞受体的内源性配体的基础上,根据线性和支化 N-乙酰-d-己糖胺均聚物进行了基于更小寡糖类似物的系统研究,这些均聚物是使用以前未探索过的反应方案合成的。系统的结构活性研究表明,四糖 GlcNAcbeta1-3(GlcNAcbeta1-4)(GlcNAcbeta1-6)GlcNAc(化合物 52)及其α-苄基衍生物 49 是 CD69 的最佳配体,IC50 高达 10(-9) M。因此,该化合物接近经典高亲和力糖基化蛋白配体 GlcNAc(23)BSA 的亲和力。通过亲水性柔性接头二聚化的化合物 68,GlcNAc 四糖 52,被证明能有效地激活 CD69(+)淋巴细胞。它还被证明能有效地增强体外自然杀伤作用,减少体内肿瘤生长,并能激活体外检查的 CD69(+)肿瘤浸润淋巴细胞。因此,该化合物是具有潜在抗肿瘤作用的基于碳水化合物的免疫调节剂的候选物。